Vanguard Global Advisers »

Denali Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 59k 19.20

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
Temasek Holdings
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein

View all funds holding Denali Therapeutics